You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 2, February 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Quality of Life
 •Liver Transplantation
 •Hepatobiliary Surgery
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Correlation of Health-Related Quality of Life After Liver Transplant With the Model for End-Stage Liver Disease Score

Eric T. Castaldo, MD, MPH; Irene D. Feurer, PhD; Robert T. Russell, MD, MPH; C. Wright Pinson, MD, MBA

Arch Surg. 2009;144(2):167-172.

Objective  To determine whether a correlation exists between the Model for End-Stage Liver Disease (MELD) score and health-related quality of life (HRQOL) after liver transplant (LT).

Design  Prospective cohort.

Setting  University hospital.

Patients  Adult LT recipients (N = 209).

Main Outcome Measures  Postoperative HRQOL over a 1-year period after LT as measured via multiple regression–based path analysis testing the effects of the MELD score, preoperative variables, and postoperative variables on scores on the physical component summary and mental component summary scales of the 36-Item Short Form Health Survey and on composite physical and mental HRQOL scores derived from multiple scales.

Results  The MELD score (β = .16), cholestatic cirrhosis (β = .12), autoimmune/metabolic disease (β = .18), neoplasm (β = .23), time after LT (β = .16), and the Karnofsky score (β = .49) had significant effects on the physical component summary scale score. Autoimmune/metabolic disease (β = .16) and the Karnofsky score (β = .25) had significant effects on the mental component summary scale score. The MELD score (β = .15), high school education (β = .15), college education (β = .17), autoimmune/metabolic disease (β = .15), neoplasm (β = .23), time after LT (β = .11), and the Karnofsky score (β = .51) had significant effects on the composite physical HRQOL score. Autoimmune/metabolic disease (β = .23), neoplasm (β = .15), and the Karnofsky score (β = .42) had significant effects on the composite mental HRQOL score.

Conclusions  An increasing MELD score, when computed without any diagnosis-based exception points, was associated with improved physical HRQOL in the first year after LT. The MELD score did not affect mental HRQOL.


Author Affiliations: Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery (Drs Castaldo, Feurer, Russell, and Pinson) and Department of Biostatistics (Dr Feurer), Vanderbilt University Medical Center, Nashville, Tennessee.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.